Form D · Other Technology
Symbiosys Corp.
Bellevue, WA · CIK 0002006048
Offering snapshot reported Dec 27, 2023 · SEC filing
- Reported sold
- $9.77M Offering amount: $11.5M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 8, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 27, 2023 | Initial | $9,769,997 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-500767
Source: Form D, filed Dec 27, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cameron Borumand | Director |
| Bashar Kachachi | Director, Executive |
| Jonathan Opdyke | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1100 Bellevue Way Ne Ste 8 A Pmb 182
Bellevue, WA, 98004
Bellevue, WA, 98004